Publication:
Clinical Manifestations, Differential Diagnosis, and Laboratory Markers

dc.contributor.authorsAlibaz-Oner F., Direskeneli H.
dc.date.accessioned2022-03-15T02:17:00Z
dc.date.accessioned2026-01-10T19:40:35Z
dc.date.available2022-03-15T02:17:00Z
dc.date.issued2021
dc.description.abstractAs a large-vessel arteritis, Takayasu’s arteritis (TAK) predominantly affects aorta and its major branches. Arterial stenosis, occlusion, and aneurysms lead to various signs and symptoms such as consitutional features, extremity pain, claudication, light-headedness, bruits, absent or diminished pulses, and loss of blood pressure. As acute-phase reactants, ESR and C-reactive protein are frequently advocated for disease assessment of TAK. Recently, a member of pentraxin family, PTX-3 was suggested to be a discriminative marker for active disease in TAK, with controversial results. Giant-cell arteritis, accelerated atherosclerosis, and various non-inflammatory vascular disorders have clinical similarities with TAK and should be investigated in the differential diagnosis. © 2021, Springer Nature Switzerland AG.
dc.identifier.doi10.1007/978-3-030-67175-4_9
dc.identifier.issn22826505
dc.identifier.urihttps://hdl.handle.net/11424/248272
dc.language.isoeng
dc.publisherSpringer Nature
dc.relation.ispartofRare Diseases of the Immune System
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAcute-phase response
dc.subjectClinical manifestations
dc.subjectDifferential diagnosis
dc.titleClinical Manifestations, Differential Diagnosis, and Laboratory Markers
dc.typebookPart
dspace.entity.typePublication
oaire.citation.endPage104
oaire.citation.startPage93
oaire.citation.titleRare Diseases of the Immune System

Files